专利检索 ap:("Vincent Brichard" OR "Aline Van Pel" OR "Catia Traversari" OR "Thomas W olfel" OR "Thierry Boon-Falleur" OR "Etienne De Plaen") AND inv:"Thomas W olfel" 第 1 页

1.

发明授权
Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2 失效
标题翻译：编码被HLA-A2呈递至少一种肿瘤排斥抗原的肿瘤排斥抗原前体的分离的核酸序列

公开(公告)号：US5620886A

公开(公告)日：1997-04-15

申请号：US32978

申请日：1993-03-18

申请人： Vincent Brichard , Aline Van Pel , Catia Traversari , Thomas W olfel , Thierry Boon-Falleur , Etienne De Plaen

发明人： Vincent Brichard , Aline Van Pel , Catia Traversari , Thomas W olfel , Thierry Boon-Falleur , Etienne De Plaen

IPC分类号： A61K38/00 , C07H21/04 , C07K14/47 , C12N5/10 , C12N15/09 , C12P21/02 , G01N33/574 , C12N5/00 , C07H19/00 , C07K1/00 , C12P21/00

CPC分类号： C07K14/4748 , G01N33/57484 , A61K38/00

摘要： The invention relates to nucleic acid molecules coding for a tumor rejection antigen precursor. Specifically, the tumor rejection antigen precursor, or "TRAP", is processed into at least one tumor rejection antigen, which is presented by HLA-A2 molecules. Ramifications of the discovery are also set forth.

摘要翻译： 本发明涉及编码肿瘤排斥抗原前体的核酸分子。具体地，将肿瘤排斥抗原前体或“TRAP”加工成由HLA-A2分子呈递的至少一种肿瘤排斥抗原。还发现了这一发现的发现。